The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000277.2(PAH):c.168G>A (p.Glu56=)

CA229457

102609 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 2be16bc3-2015-45e9-b854-cbb09e3aa99b
Approved on: 2019-11-10
Published on: 2020-01-25

HGVS expressions

NM_000277.2:c.168G>A
NM_000277.2(PAH):c.168G>A (p.Glu56=)
NM_000277.1:c.168G>A
NM_001354304.1:c.168G>A
NM_000277.3:c.168G>A
NM_001354304.2:c.168G>A
ENST00000307000.7:c.153G>A
ENST00000546844.1:c.168G>A
ENST00000548677.2:n.255G>A
ENST00000548928.1:n.90G>A
ENST00000549111.5:n.264G>A
ENST00000550978.6:n.152G>A
ENST00000551337.5:c.168G>A
ENST00000551988.5:n.257G>A
ENST00000553106.5:c.168G>A
ENST00000635500.1:n.136G>A
NC_000012.12:g.102912791C>T
CM000674.2:g.102912791C>T
NC_000012.11:g.103306569C>T
CM000674.1:g.103306569C>T
NC_000012.10:g.101830699C>T
NG_008690.1:g.9812G>A
NG_008690.2:g.50620G>A

Uncertain Significance

Met criteria codes 4
PP3 PM2 BS2 BP2
Not Met criteria codes 3
PP4 PM5 BP7

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.168G>A (p.Glu56=) variant in PAH has been reported as a polymoprhism. It was found in Arab patients’ DNA, including patients and controls (zygosity not reported). (BS2; PMID: 18299955) However, this variant is absent from 1000G, ESP, ExAC and gnomAD (PM2). While it is a synonymous variant, alteration of the WT donor site affecting splicing is suggested by Human Splicing Finder and Alamut (PP3). It was observed in cis with a pathogenic variant, IVS2+1G>A (BP2; PMID: 24368688). In summary, this variant meets criteria to be classified as uncertain significance for PAH due to conflicting evidence. ACMG/AMP criteria applied: BS2, BP2, PM2, PP3.
Met criteria codes
PP3
HSF: Alteration of the WT donor site, most probably affecting splicing. Alamut: Reduces/eliminates splicing at donor site. (-.78 reduction).
PM2
Absent from ExAC, gnomAD, 1000G, ESP
BS2
The E56E SNP was found in Arab patients’ DNA, including patients and controls. PMID: 18299955. (zygosity not reported)

BP2
Observed in cis with IVS2+1G>A (LP in ClinVar) PMID: 24368688

Not Met criteria codes
PP4
The E56E SNP was found in Arab patients’ DNA (13.8%), including patients and controls. PMID: 18299955.

PM5
E56D, no assertion provided
BP7
HSF: Alteration of the WT donor site, most probably affecting splicing. Alamut: Reduces/eliminates splicing at donor site. (-.78 reduction)
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.